PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 207 filers reported holding PTC THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,660,454 | +102.5% | 152,402 | +92.7% | 0.00% | 0.0% |
| Q1 2024 | $2,300,933 | +5.6% | 79,097 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $2,179,914 | +28.5% | 79,097 | +4.5% | 0.00% | 0.0% |
| Q3 2023 | $1,697,019 | -52.3% | 75,726 | +3.0% | 0.00% | -50.0% |
| Q2 2023 | $3,559,855 | 0.0% | 73,490 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,559,855 | +37.4% | 73,490 | +8.3% | 0.00% | +100.0% |
| Q4 2022 | $2,590,559 | -100.0% | 67,869 | -74.1% | 0.00% | -85.7% |
| Q3 2022 | $13,150,844,000 | +18.8% | 261,969 | -5.2% | 0.01% | +16.7% |
| Q2 2022 | $11,066,776,000 | -36.5% | 276,255 | -40.9% | 0.01% | -14.3% |
| Q1 2022 | $17,431,456,000 | -8.9% | 467,206 | -2.7% | 0.01% | 0.0% |
| Q4 2021 | $19,126,924,000 | +7.7% | 480,214 | +0.6% | 0.01% | 0.0% |
| Q3 2021 | $17,760,707,000 | -8.7% | 477,310 | +3.7% | 0.01% | -12.5% |
| Q2 2021 | $19,461,107,000 | +30.0% | 460,400 | +45.6% | 0.01% | +14.3% |
| Q1 2021 | $14,972,165,000 | -44.8% | 316,202 | -28.8% | 0.01% | -46.2% |
| Q4 2020 | $27,105,986,000 | +35.6% | 444,142 | +3.9% | 0.01% | +18.2% |
| Q3 2020 | $19,982,821,000 | -19.9% | 427,440 | -13.1% | 0.01% | -26.7% |
| Q2 2020 | $24,953,019,000 | +52.0% | 491,782 | +33.6% | 0.02% | +25.0% |
| Q1 2020 | $16,420,316,000 | -14.2% | 368,086 | -7.7% | 0.01% | 0.0% |
| Q4 2019 | $19,145,046,000 | +52.5% | 398,606 | +7.4% | 0.01% | +50.0% |
| Q3 2019 | $12,554,931,000 | -23.6% | 371,228 | +1.6% | 0.01% | -33.3% |
| Q2 2019 | $16,440,615,000 | +42.2% | 365,347 | +19.0% | 0.01% | +33.3% |
| Q1 2019 | $11,559,245,000 | +22.2% | 307,100 | +11.4% | 0.01% | +12.5% |
| Q4 2018 | $9,458,970,000 | -22.1% | 275,611 | +6.7% | 0.01% | -11.1% |
| Q3 2018 | $12,137,468,000 | +31.2% | 258,244 | -5.9% | 0.01% | +28.6% |
| Q2 2018 | $9,252,409,000 | +12.8% | 274,308 | -9.5% | 0.01% | +16.7% |
| Q1 2018 | $8,202,102,000 | +36.0% | 303,108 | -16.2% | 0.01% | +20.0% |
| Q4 2017 | $6,029,703,000 | -8.4% | 361,493 | +9.8% | 0.01% | -16.7% |
| Q3 2017 | $6,585,231,000 | -7.4% | 329,097 | -15.2% | 0.01% | -14.3% |
| Q2 2017 | $7,110,152,000 | +17.3% | 387,897 | -37.0% | 0.01% | +16.7% |
| Q1 2017 | $6,061,017,000 | +92392.2% | 615,957 | +2.6% | 0.01% | -14.3% |
| Q4 2016 | $6,553,000 | -23.1% | 600,612 | -1.2% | 0.01% | -22.2% |
| Q3 2016 | $8,519,000 | +97.2% | 608,077 | -1.2% | 0.01% | +80.0% |
| Q2 2016 | $4,321,000 | +5.4% | 615,531 | -3.3% | 0.01% | 0.0% |
| Q1 2016 | $4,098,000 | -73.4% | 636,300 | +34.0% | 0.01% | -72.2% |
| Q4 2015 | $15,381,000 | +16.6% | 474,710 | -3.9% | 0.02% | +20.0% |
| Q3 2015 | $13,188,000 | -24.5% | 493,928 | +36.2% | 0.02% | -11.8% |
| Q2 2015 | $17,460,000 | -7.0% | 362,775 | +17.6% | 0.02% | -5.6% |
| Q1 2015 | $18,778,000 | +19.1% | 308,600 | +1.3% | 0.02% | +20.0% |
| Q4 2014 | $15,769,000 | +31.0% | 304,600 | +11.3% | 0.02% | +25.0% |
| Q3 2014 | $12,041,000 | – | 273,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 8,180 | $382,000 | 7.47% |
| Burrage Capital Management LLC | 173,545 | $8,113,000 | 6.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 299,000 | $13,951,000 | 4.50% |
| RTW INVESTMENTS, LP | 3,993,286 | $186,686,000 | 4.50% |
| SECTORAL ASSET MANAGEMENT INC | 669,578 | $31,303,000 | 2.69% |
| Third Security, LLC | 255,873 | $11,962,000 | 2.48% |
| Sofinnova Investments, Inc. | 405,152 | $18,941,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 724,000 | $33,847,000 | 1.23% |
| Redwood Investments, LLC | 225,355 | $10,535,000 | 0.89% |
| Handelsinvest Investeringsforvaltning | 60,000 | $2,805,000 | 0.53% |